
Medicago, a biopharmaceutical company headquartered in Quebec City, Canada, announced on Thursday that they have successfully produced a Virus-Like Particle (VLP) of the coronavirus just 20 days after obtaining the SARS-CoV-2 (virus causing the COVID-19 disea⦠[+2820 chars]Source